Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis A Report of the Association for Molecular Pathology

Overview of attention for article published in The Journal of Molecular Diagnostics, April 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 5 news outlets
policy: 1 policy source
twitter: 10 X users

facebook: 3 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 150 Mendeley

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 28,282 followers.

DP few eg of economic value in community setting (oncotype Dx, Her2, Allomap); some on value of approach eg. https://t.co/Y2QlG7oVss #2ndPM

RT @PathologyTweet: Genomic Sequencing Procedure Microcosting Analysis & Health Economic Cost-Impact Analysis: A Report of the @AMPath http…

Genomic Sequencing Procedure Microcosting Analysis & Health Economic Cost-Impact Analysis: A Report of the @AMPath https://t.co/J2FaAET43g

RT @ventana: Genomic #Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis via @JMDiagn https://t.co/kBRJOKq…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.